Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
22.99
-0.40 (-1.71%)
At close: Mar 13, 2026, 4:00 PM EDT
23.44
+0.45 (1.96%)
After-hours: Mar 13, 2026, 7:42 PM EDT
Enovis Revenue
In the year 2025, Enovis had annual revenue of $2.25B with 6.66% growth. Enovis had revenue of $575.76M in the quarter ending December 31, 2025, with 2.64% growth.
Revenue (ttm)
$2.25B
Revenue Growth
+6.66%
P/S Ratio
0.59
Revenue / Employee
$288,138
Employees
7,802
Market Cap
1.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.25B | 140.43M | 6.66% |
| Dec 31, 2024 | 2.11B | 400.43M | 23.46% |
| Dec 31, 2023 | 1.71B | 144.10M | 9.22% |
| Dec 31, 2022 | 1.56B | 136.91M | 9.60% |
| Dec 31, 2021 | 1.43B | 305.49M | 27.26% |
| Dec 31, 2020 | 1.12B | -2.21B | -66.32% |
| Dec 31, 2019 | 3.33B | 1.13B | 51.73% |
| Dec 31, 2018 | 2.19B | 255.80M | 13.20% |
| Dec 31, 2017 | 1.94B | -1.25B | -39.19% |
| Dec 31, 2016 | 3.19B | -248.60M | -7.24% |
| Dec 31, 2015 | 3.43B | -1.19B | -25.74% |
| Dec 31, 2014 | 4.62B | 417.27M | 9.92% |
| Dec 31, 2013 | 4.21B | 293.35M | 7.50% |
| Dec 31, 2012 | 3.91B | 3.22B | 464.45% |
| Dec 31, 2011 | 693.39M | 151.41M | 27.94% |
| Dec 31, 2010 | 541.99M | 16.96M | 3.23% |
| Dec 31, 2009 | 525.02M | -79.83M | -13.20% |
| Dec 31, 2008 | 604.85M | 98.55M | 19.46% |
| Dec 31, 2007 | 506.31M | 112.70M | 28.63% |
| Dec 31, 2006 | 393.60M | 48.13M | 13.93% |
| Dec 31, 2005 | 345.48M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.24B |
| QuidelOrtho | 2.73B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.01B |
| Lumexa Imaging Holdings | 1.00B |
| Inspire Medical Systems | 911.98M |
| NovoCure | 655.35M |
| UFP Technologies | 602.80M |
ENOV News
- 5 days ago - Royce Small-Cap Fund FY 2025: What Worked - Seeking Alpha
- 7 days ago - Canfor Pulp Products Inc. (CFX:CA) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 15 days ago - Enovis Corporation (ENOV) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Update: Enovis Announces Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 15 days ago - Enovis Announces Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 4 weeks ago - Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth - Seeking Alpha
- 5 weeks ago - Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - GlobeNewsWire
- 7 weeks ago - Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th - GlobeNewsWire